Chronic Tumor Necrosis Factor-α Treatment Causes Insulin Resistance via Insulin Receptor Substrate-1 Serine Phosphorylation and Suppressor of Cytokine Signaling-3 Induction in 3T3-L1 Adipocytes

  • Ken Ishizuka
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Isao Usui
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Yukiko Kanatani
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Agussalim Bukhari
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Jianying He
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Shiho Fujisaka
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Yu Yamazaki
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Hikari Suzuki
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Kazuyuki Hiratani
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Manabu Ishiki
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Minoru Iwata
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Masaharu Urakaze
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Tetsuro Haruta
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
  • Masashi Kobayashi
    The First Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan

この論文をさがす

説明

<jats:p>Serine phosphorylation of insulin receptor substrate (IRS)-1 and the induction of suppressor of cytokine signaling 3 (SOCS3) is recently well documented as the mechanisms for the insulin resistance. However, the relationship between these two mechanisms is not fully understood. In this study, we investigated the involvement of SOCS3 and IRS-1 serine phosphorylation in TNFα-induced insulin resistance in 3T3-L1 adipocytes. TNFα transiently stimulated serine phosphorylation of IRS-1 from 10 min to 1 h, whereas insulin-stimulated IRS-1 tyrosine phosphorylation was inhibited only after TNFα treatment longer than 4 h. These results suggest that serine phosphorylation of IRS-1 alone is not the major mechanism for the inhibited insulin signaling by TNFα. TNFα stimulation longer than 4 h enhanced the expression of SOCS3 and signal transducer and activator of transcription-3 phosphorylation, concomitantly with the production of IL-6. Anti-IL-6 neutralizing antibody ameliorated suppressed insulin signaling by 24 h TNFα treatment, when it partially decreased SOCS3 induction and signal transducer and activator of transcription-3 phosphorylation. These results suggest that SOCS3 induction is involved in inhibited insulin signaling by TNFα. However, low-level expression of SOCS3 by IL-6 or adenovirus vector did not affect insulin-stimulated IRS-1 tyrosine phosphorylation. Interestingly, when IRS-1 serine phosphorylation was enhanced by TNFα or anisomycin in the presence of low-level SOCS3, IRS-1 degradation was remarkably enhanced. Taken together, both IRS-1 serine phosphorylation and SOCS3 induction are necessary, but one of the pair is not sufficient for the inhibited insulin signaling. Chronic TNFα may inhibit insulin signaling effectively because it causes both IRS-1 serine phosphorylation and the following SOCS3 induction in 3T3-L1 adipocytes.</jats:p>

収録刊行物

  • Endocrinology

    Endocrinology 148 (6), 2994-3003, 2007-06-01

    The Endocrine Society

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ